#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Dementia Alzheimer's type Anti-glomerular basement membrane disease Mantle cell lymphoma stage II Red blood cell abnormality Atypical haemolytic uraemic syndrome White matter lesion Cervix carcinoma recurrent Biliary neoplasm Juvenile psoriatic arthritis Epidermolysis bullosa Myeloproliferative neoplasm Metabolic disorder Mitochondrial DNA depletion Complex regional pain syndrome Pyoderma gangrenosum More trials…

    Learn about Rare Diseases

    Metachromatic leukodystrophy – Life with Disease Ewing’s sarcoma metastatic – Life with Disease Extranodal marginal zone B-cell lymphoma (MALT type) – Treatment Hyperoxaluria – Basic Information Idiopathic inflammatory myopathy – Trials in Disease Alternating hemiplegia of childhood – Diagnostics Factor IX deficiency – Trials in Disease Urea cycle disorder – Diagnostics Myxofibrosarcoma – Diagnostics Von Willebrand’s disease – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    FOSFOMYCIN CALCIUM Sodium Picosulfate IMA401 Amylase ANX007 Nelarabine Metoclopramide Calcium Folinate Pentahydrate Antiemetics And Antinauseants Tilsotolimod Sodium [11C]Az14193391 Dinoprostone Itolizumab Xaluritamig Gfh925 ADX-038 Lymecycline Murcidencel Povetacicept Relacorilant More therapies…

    Learn about Your Condition

    Pleural mesothelioma malignant Stevens-Johnson syndrome Pancreatic neoplasm Pulmonary tuberculosis Pulmonary resection Eosinophilic oesophagitis Asthma Sleep disorder Cardiac arrest Chondrocalcinosis Neuralgia Myocarditis Oesophageal disorder Advanced systemic mastocytosis Catatonia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Congenital, Hereditary, and Neonatal Diseases and Abnormalities

  • Study on the Effect of Dapagliflozin on Blood Magnesium Levels in Patients with Low Magnesium Due to HNF1beta-Associated Kidney Disease

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Hypomagnesaemia
    Investigated Drugs:
    • Dapagliflozin
    • Placebo
    The Netherlands

  • Long-Term Safety Study of Avalglucosidase Alfa for Patients with Pompe Disease in France

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Avalglucosidase Alfa
    France

  • Long-term Safety Study of Onasemnogene Abeparvovec for Patients with Spinal Muscular Atrophy

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Spinal muscular atrophy
    Investigated Drugs:
    • Onasemnogene Abeparvovec
    Belgium Denmark France Italy The Netherlands Spain

  • Long-term Safety Study of Dasiglucagon for Children with Congenital Hyperinsulinism

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Dasiglucagon
    Germany

  • Study on Automatic Oxygen Control for Extremely Preterm Infants Using Oxygen PH.EUR.

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Bronchopulmonary dysplasia
    • Death neonatal
    • Infantile apnoea
    Investigated Drugs:
    • Oxygen Ph.eur.
    Germany

  • Study on the Effects of ISIS 678354 in Patients with Familial Chylomicronemia Syndrome (FCS)

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Familial hypertriglyceridaemia
    • Hyperchylomicronaemia
    Investigated Drugs:
    • Isis 678354 Sodium Salt
    France Italy The Netherlands Portugal Slovakia Spain +1
Previous Page
1 … 27 28 29 30 31 … 45
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!